Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05690399 | Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer | unknown | — | 100 | Assiut UniversityOTHER | 0 | Jan 19, 2023 | clinicaltrials |
| NCT03845751 | EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.(ENHANCE) | unknown | Phase 2 | 20 | Institut Mutualiste MontsourisOTHER | 1 | Jan 12, 2023 |
| clinicaltrials |
| NCT05669872 | Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer | unknown | N/A | 334 | Asan Medical CenterOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05249712 | Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer | unknown | Phase 2 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 3, 2023 | clinicaltrials |
| NCT02125513 | Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer(GOGER-01) | unknown | Phase 2 | 129 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 30, 2022 | clinicaltrials |
| NCT04770376 | Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab | unknown | — | 150 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT05665023 | Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma | unknown | Phase 2 | 37 | Yonsei UniversityOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT05662839 | Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions(BRUCY) | unknown | N/A | 50 | The Christie NHS Foundation TrustOTHER | 0 | Dec 23, 2022 | clinicaltrials |
| NCT04356430 | Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer | unknown | Phase 2 | 75 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT03162289 | Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers(FIT2) | unknown | N/A | 150 | Charite University, Berlin, GermanyOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT02446366 | Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery | unknown | N/A | 24 | University of Southern CaliforniaOTHER | 1 | Dec 12, 2022 | clinicaltrials |
| NCT05644197 | Multidisciplinary Care After Prostatectomy(MCAP) | unknown | N/A | 100 | Provence Private hospitalOTHER | 0 | Dec 9, 2022 | clinicaltrials |
| NCT04833517 | Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | unknown | — | 500 | Universität des SaarlandesOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05642871 | DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene | unknown | — | 2 | Qianqian QuOTHER | 0 | Dec 8, 2022 | clinicaltrials |
| NCT05640024 | Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors | unknown | — | 54 | Yonsei UniversityOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05641506 | A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer | unknown | Phase 2 | 50 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05638256 | 68Ga-labeled NY104 PET Imaging in Patients | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04730219 | Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma | unknown | Phase 2 | 48 | Tianjin Medical University Second HospitalOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | unknown | Phase 3 | 498 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05631080 | Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer | unknown | Phase 4 | 50 | Mansoura UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05456074 | Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)(IMCOR) | unknown | — | 600 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT05622890 | A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer | unknown | Phase 3 | 35 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 21, 2022 | clinicaltrials |
| NCT05620654 | A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin | unknown | Phase 1 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT03540017 | HIPEC After Initial CRS in Patients Who Have Received NACT | unknown | Phase 1 | 15 | Northwell HealthOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05005195 | Yorkshire Kidney Screening Trial(YKST) | unknown | N/A | 5,850 | University of LeedsOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05602831 | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer | unknown | — | 108 | Fudan UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05603351 | Prostate Cancer Screening With Abbreviated MRI Protocol(ProstaPilot) | unknown | N/A | 300 | Masaryk Memorial Cancer InstituteOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05480735 | EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy(ENHANCE) | unknown | N/A | 154 | The Netherlands Cancer InstituteOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT04457882 | Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube | unknown | N/A | 112 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05025527 | Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | unknown | N/A | 500 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05597527 | Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer | unknown | Phase 2 | 35 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05596851 | Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. | unknown | — | 15 | European Institute of OncologyOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT03936127 | Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy | unknown | N/A | 360 | Dr. Nicola SchiedaOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05167175 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | unknown | Phase 2 | 30 | Hongqian GuoOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05591560 | Itraconazole in Advanced Ovarian Cancer | unknown | N/A | 66 | Tanta UniversityOTHER | 1 | Oct 24, 2022 | clinicaltrials |
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion(CRADT) | unknown | N/A | 70 | Tongji HospitalOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT04026230 | Impact of Atorvastatin on Prostate Cancer Progression During ADT(ESTO2) | unknown | Phase 3 | 400 | Tampere University HospitalOTHER | 4 | Oct 21, 2022 | clinicaltrials |
| NCT03529890 | Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder(RACE IT) | unknown | Phase 2 | 33 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT03601143 | Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients(PEARL) | unknown | — | 120 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05179720 | The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy | unknown | N/A | 560 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT05583799 | Efficacy and Adverse Effects of Niraparib in Ovarian Cancer. | unknown | — | 222 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Oct 18, 2022 | clinicaltrials |
| NCT05179707 | A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer | unknown | — | 936 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05437692 | Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 19 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05576519 | Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05432687 | Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)(PROSTABDO) | unknown | N/A | 80 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05572099 | ExoDx Prostate Evaluation in Active Surveillance Patient Population | unknown | — | 750 | Exosome Diagnostics, Inc.INDUSTRY | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05570331 | Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women | unknown | — | 2,200 | Ding MaOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Oct 4, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jan 19, 2023source: clinicaltrials